Clinical Trials Directory

Trials / Completed

CompletedNCT00469755

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-week Treatment Switched to Tazorac® Cream, 0.1% 6-week Treatment in Patients With Acne Vulgaris

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
302 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
12 Years – 35 Years
Healthy volunteers
Not accepted

Summary

To determine the efficacy and safety of 12 weeks of treatment with Differin Gel, 0.1% compared to 12 weeks of treatment with Tazorac Cream, 0.1% and compared to 6 weeks treatment with Differin Gel, 0.1% followed by 6 weeks of treatment with Tazorac Cream

Detailed description

Same as above.

Conditions

Interventions

TypeNameDescription
DRUGAdapalene Gel, 0.1%Apply once daily in the evening for 12 weeks
DRUGTazarotene Cream, 0.1%Apply once daily in the evening for 12 weeks
DRUGAdapalene Gel, 0.1% + Tazarotene Cream, 0.1%Apply adapalene Gel, 0.1% once daily in the evening for 6 weeks and Tazarotene Cream, 0.1% once daily in the evening for 6 weeks

Timeline

Start date
2006-02-01
Primary completion
2006-09-01
Completion
2006-09-01
First posted
2007-05-04
Last updated
2022-07-29

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00469755. Inclusion in this directory is not an endorsement.